Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab induction study in moderately to severely active ulcerative colitis
NL-OMON30549Phase 3Recruiting
- Sponsor
- Abbott Laboratories
- Start
- Aug 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of adalimumab, sponsored by Abbott Laboratories. Started Aug 2007; status: recruiting.
02
Drugs
Beyond the preview
Go deeper on NL-OMON30549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30549.